|
pain
| Date |
Article Rating |
Type |
Title |
|
Sep 27, 2002 |
|
Article |
Growing Evidence Shows Commonly Used Medicines May Delay or Prevent Alzheimer’s
Have researchers found yet another reason to take an aspirin a day? Aspirin has been found to benefit cardiac patients. Now a new study reported in the current issue of Neurology, presents additional evidence that regular use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the incidence of dementia in elderly people, but only when taken for more than two years.
|
|
Dec 13, 2002 |
|
Article |
Forgetfulness: It's Not Always What You Think
Many older people worry about becoming more forgetful. They think forgetfulness is the first sign of Alzheimer's disease. In the past, memory loss and confusion were considered a normal part of aging. However, scientists now know that most people remain both alert and able as they age, although it may take them longer to remember things.
|
|
Jul 19, 2002 |
|
Article |
Survey Shows Healthcare Systems Delay Alzheimer's Disease Diagnosis, Treatment
According to results from a new multi-country survey of Alzheimer's Disease caregivers, some 80 percent of patients with Alzheimer's remained undiagnosed after presenting symptoms to their general practitioner or family physician.
|
|
Jul 15, 2002 |
|
MyStory |
Becoming a Stranger to My Mom
A personal account of how a daughter copes when her mother is deteriorating due to Alzheimer's Disease.
|
|
Mar 31, 2003 |
|
Article |
Safe Return Program Highlights the Dangers of Alzheimer's Disease and Wandering
Wandering is one of the most frightening and potentially life-threatening behaviors that may accompany Alzheimer's disease, and often, one of the first warning signs of the disease. As many as 60 percent of the 4 million Americans with Alzheimer's disease will wander at some point, often leaving home and unable to find their way back. |
|
Jun 19, 2002 |
|
Email Bulletin |
New Urine Test Predicts Alzheimer's Disease
A urine sample taken at the doctor's office can be the first step in determining your chances of developing Alzheimer's disease. Researchers from the University of Pennsylvania School of Medicine have determined that a urine test can reliably detect free radical damage associated with Mild Cognitive Impairment – a recognized precursor to Alzheimer’s.
|
|
Dec 12, 2001 |
|
Article |
Aricept Better Tolerated than Exelon in Patients with Mild to Moderate AD
Results from the first head-to-head study between Aricept (donepezil hydrochloride) and Exelon (rivastigmine tartrate) showed that in this open-label study, Aricept was better tolerated than Exelon, in patients with mild to moderate Alzheimer’s disease. The findings were presented at a scientific conference held recently in Munich, Germany.
|
|
Jan 03, 2006 |
|
Article |
UCSD Researchers State Vitamin D Needed to Cut Cancer Risk
Taking 1,000 international units (IU) of vitamin D3 daily appears to lower an individual's risk of developing certain cancers – including colon, breast, and ovarian cancer – by up to 50 percent, according to cancer prevention specialists at the Moores Cancer Center at the University of California, San Diego (UCSD) Medical Center. |
|
Dec 21, 2004 |
|
Article |
Poem: "Alzheimer's...prison of the mind"
Christine Elaine Bean writes, "This is dedicated to my Dad. The man who raised me, loved me, fought for me and our country. Little did he know that the biggest battle he would fight would be within. Thank you for fighting so many battles, especially this one. He's a hero." |
|
Apr 15, 2004 |
|
Article,DrugNews |
New Study Results Show Benefit for Alzheimer's Disease Patients Taking Lipitor(TM)
Results of a Sun City, Arizona research study unveiled today in Montreal showed that Lipitor(TM), a cholesterol-lowering medication, slows the progression and reduces the deterioration of Alzheimer's Disease (AD). |
|
|
Next 10 Articles>> |
|
|
|